Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Current Infectious Disease Reports
|
August 25, 2020
Clinical Utility of Lefamulin: If Not Now, When?
Nicholas J Mercuro, Michael P Veve
International Journal of Antimicrobial Agents
|
December 29, 2017
Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams
Nicholas J Mercuro, Patricia Stogsdill, Minkey Wungwattana
Jac-Antimicrobial Resistance
|
October 5, 2022
Predictors of discordant MRSA nares and respiratory cultures in patients with pneumonia
Nicholas P Palisano, Christina F Yen, Nicholas J Mercuro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 17, 2018
Ambulatory Quinolone Prescribing: Moving From Opportunity to Implementation
Nicholas J Mercuro, Rachel M Kenney, Odaliz Abreu-Lanfranco, et al.
Expert Opinion on Pharmacotherapy
|
June 8, 2018
Combatting resistant enterococcal infections: a pharmacotherapy review
Nicholas J Mercuro, Susan L Davis, Marcus J Zervos, et al.
Frontiers in Medicine
|
May 30, 2024
Case report: Successful treatment of OXA-23 <i>Acinetobacter baumannii</i> neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy
Jacob W Snowdin, Nicholas J Mercuro, Michael P Madaio, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
March 1, 2022
Pharmacokinetics of Cefazolin in Patients With Obesity Undergoing Surgery Requiring Cardiopulmonary Bypass
Justin Poltak, Christopher Connors, Minkey Wungwattana, et al.
Open Forum Infectious Diseases
|
July 25, 2022
Prevalence and Predictors of <i>Pseudomonas aeruginosa</i> Among Hospitalized Patients With Diabetic Foot Infections
Michael P Veve, Nicholas J Mercuro, Ryan J Sangiovanni, et al.
International Journal of Antimicrobial Agents
|
February 22, 2023
Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae
Brian E Frescas, Christopher M McCoy, James Kirby, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2021
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
Catherine Li, Nicholas J Mercuro, Ryan W Chapin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Current Infectious Disease Reports
|
August 25, 2020
Clinical Utility of Lefamulin: If Not Now, When?
Nicholas J Mercuro, Michael P Veve
International Journal of Antimicrobial Agents
|
December 29, 2017
Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams
Nicholas J Mercuro, Patricia Stogsdill, Minkey Wungwattana
Jac-Antimicrobial Resistance
|
October 5, 2022
Predictors of discordant MRSA nares and respiratory cultures in patients with pneumonia
Nicholas P Palisano, Christina F Yen, Nicholas J Mercuro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 17, 2018
Ambulatory Quinolone Prescribing: Moving From Opportunity to Implementation
Nicholas J Mercuro, Rachel M Kenney, Odaliz Abreu-Lanfranco, et al.
Expert Opinion on Pharmacotherapy
|
June 8, 2018
Combatting resistant enterococcal infections: a pharmacotherapy review
Nicholas J Mercuro, Susan L Davis, Marcus J Zervos, et al.
Frontiers in Medicine
|
May 30, 2024
Case report: Successful treatment of OXA-23 <i>Acinetobacter baumannii</i> neurosurgical infection and meningitis with sulbactam-durlobactam combination therapy
Jacob W Snowdin, Nicholas J Mercuro, Michael P Madaio, et al.
Journal of Cardiothoracic and Vascular Anesthesia
|
March 1, 2022
Pharmacokinetics of Cefazolin in Patients With Obesity Undergoing Surgery Requiring Cardiopulmonary Bypass
Justin Poltak, Christopher Connors, Minkey Wungwattana, et al.
Open Forum Infectious Diseases
|
July 25, 2022
Prevalence and Predictors of <i>Pseudomonas aeruginosa</i> Among Hospitalized Patients With Diabetic Foot Infections
Michael P Veve, Nicholas J Mercuro, Ryan J Sangiovanni, et al.
International Journal of Antimicrobial Agents
|
February 22, 2023
Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae
Brian E Frescas, Christopher M McCoy, James Kirby, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2021
Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
Catherine Li, Nicholas J Mercuro, Ryan W Chapin, et al.
Page
of 3